|
LLY
|
Healthcare |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$917.2B
|
$226.10
|
+0.0%
|
-1.1%
|
-1.2%
|
+0.7%
|
-1.6%
|
+1.9%
|
|
XOM
|
Energy |
Credit Suisse |
Maintains
|
Neutral
→
Neutral
|
—
|
$699.8B
|
$62.07
|
+0.7%
|
+3.6%
|
-0.4%
|
-3.3%
|
-2.6%
|
+3.6%
|
|
BAC
|
Financial Services |
Credit Suisse |
Maintains
|
Outperform
→
Outperform
|
—
|
$386.6B
|
$41.36
|
-0.2%
|
+0.1%
|
+0.6%
|
-4.4%
|
-2.6%
|
+2.5%
|
|
WFC
|
Financial Services |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$239.9B
|
$45.15
|
+0.1%
|
+0.7%
|
+0.2%
|
-6.1%
|
-2.4%
|
+3.7%
|
|
BA
|
Industrials |
Berenberg |
Maintains
|
Hold
→
Hold
|
—
|
$169.4B
|
$245.14
|
+0.1%
|
+0.6%
|
-1.7%
|
-1.3%
|
-0.8%
|
+3.3%
|
|
TMO
|
Healthcare |
Goldman Sachs |
Maintains
|
Buy
→
Buy
|
—
|
$168.8B
|
$470.07
|
+0.6%
|
+0.0%
|
-0.4%
|
+3.8%
|
-0.7%
|
+0.2%
|
|
UNP
|
Industrials |
Deutsche Bank |
Maintains
|
Buy
→
Buy
|
—
|
$161.2B
|
$222.62
|
+0.4%
|
+0.1%
|
-0.3%
|
-1.3%
|
-1.9%
|
+1.3%
|
|
WELL
|
Real Estate |
Wolfe Research |
Maintains
|
Outperform
→
Outperform
|
—
|
$148.1B
|
$81.21
|
+1.1%
|
-0.1%
|
-0.4%
|
-0.3%
|
-2.5%
|
+2.6%
|
|
WELL
|
Real Estate |
Raymond JamesA |
Upgrade
|
Market Perform
→
Strong Buy
|
—
|
$148.1B
|
$81.21
|
+1.1%
|
-0.1%
|
-0.4%
|
-0.3%
|
-2.5%
|
+2.6%
|
|
PLD
|
Real Estate |
Wolfe Research |
Maintains
|
Peer Perform
→
Perform
|
—
|
$136.5B
|
$126.16
|
-0.7%
|
-2.4%
|
-1.4%
|
+1.0%
|
-2.5%
|
+2.5%
|
|
ACN
|
Technology |
Societe Generale |
Maintains
|
Buy
→
Buy
|
—
|
$113.3B
|
$285.71
|
+0.4%
|
+0.2%
|
-0.8%
|
+0.3%
|
-1.2%
|
+1.5%
|
|
ADBE
|
Technology |
BMO Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$108.2B
|
$556.95
|
-0.4%
|
-1.5%
|
-0.9%
|
+1.5%
|
+2.6%
|
+0.3%
|
|
CSX
|
Industrials |
Deutsche Bank |
Maintains
|
Buy
→
Buy
|
—
|
$85.9B
|
$32.43
|
+0.8%
|
+1.1%
|
-1.2%
|
-1.0%
|
-1.6%
|
+1.1%
|
|
PSA
|
Real Estate |
Wolfe Research |
Maintains
|
Peer Perform
→
Perform
|
—
|
$52.3B
|
$294.63
|
-0.2%
|
-0.5%
|
-0.3%
|
+1.2%
|
+0.9%
|
+1.7%
|
|
FAST
|
Industrials |
Morgan Stanley |
Downgrade
|
Equal Weight
→
Underweight
|
—
|
$50.1B
|
$26.37
|
-3.4%
|
-2.2%
|
-1.0%
|
-1.4%
|
+0.8%
|
+1.5%
|
|
VTR
|
Real Estate |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$40.9B
|
$58.96
|
+1.2%
|
-0.9%
|
-1.1%
|
+0.1%
|
-2.1%
|
+1.9%
|
|
CBRE
|
Real Estate |
Wolfe Research |
Maintains
|
Outperform
→
Outperform
|
—
|
$39.4B
|
$87.70
|
+0.9%
|
+1.6%
|
-1.5%
|
-0.5%
|
-1.1%
|
+3.1%
|
|
CUK
|
Consumer Cyclical |
Wolfe ResearchB |
Upgrade
|
Peer Perform
→
Outperform
|
—
|
$38.5B
|
$25.02
|
-0.2%
|
-0.8%
|
+1.9%
|
-2.4%
|
-1.9%
|
+3.3%
|
|
NTR
|
Basic Materials |
Raymond James |
Downgrade
|
Strong Buy
→
Outperform
|
—
|
$34.8B
|
$63.73
|
-0.4%
|
-0.9%
|
-2.1%
|
-4.1%
|
-2.0%
|
+2.7%
|
|
RMD
|
Healthcare |
Oppenheimer |
Maintains
|
Outperform
→
Outperform
|
—
|
$30.6B
|
$231.70
|
+0.2%
|
+2.1%
|
+0.1%
|
+1.5%
|
-1.3%
|
+0.9%
|